ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $256,000 | -2.3% | 9,111 | -9.7% | 0.00% | – |
Q4 2020 | $262,000 | -73.7% | 10,087 | -68.1% | 0.00% | -100.0% |
Q1 2020 | $998,000 | -45.5% | 31,655 | +3.1% | 0.00% | -50.0% |
Q4 2019 | $1,831,000 | -36.6% | 30,712 | -61.0% | 0.00% | -33.3% |
Q3 2019 | $2,890,000 | +3.1% | 78,845 | +30.9% | 0.00% | 0.0% |
Q2 2019 | $2,803,000 | +20.2% | 60,249 | +14.7% | 0.00% | +50.0% |
Q3 2018 | $2,331,000 | +106.6% | 52,544 | +82.6% | 0.00% | +100.0% |
Q2 2018 | $1,128,000 | -45.9% | 28,775 | -0.1% | 0.00% | -50.0% |
Q1 2018 | $2,084,000 | +29.9% | 28,812 | +18.2% | 0.00% | 0.0% |
Q4 2017 | $1,604,000 | -18.2% | 24,367 | +1.6% | 0.00% | 0.0% |
Q2 2015 | $1,961,000 | +22.9% | 23,980 | +39.2% | 0.00% | 0.0% |
Q1 2015 | $1,595,000 | – | 17,224 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |